Cancer Research Cancer Epigenetics  Protein Translation and Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 68, 8582, October 15, 2008. doi: 10.1158/0008-5472.CAN-08-1673
© 2008 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Taranova, A. G.
Right arrow Articles by Lee, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taranova, A. G.
Right arrow Articles by Lee, J. J.

Prevention

Allergic Pulmonary Inflammation Promotes the Recruitment of Circulating Tumor Cells to the Lung

Anna G. Taranova1, David Maldonado, III3, Celine M. Vachon4, Elizabeth A. Jacobsen1, Hiam Abdala-Valencia6, Michael P. McGarry1, Sergei I. Ochkur1, Cheryl A. Protheroe1,2, Alfred Doyle1,2, Clive S. Grant5, Joan Cook-Mills6, Lutz Birnbaumer7, Nancy A. Lee2 and James J. Lee1

Divisions of 1 Pulmonary Medicine and 2 Hematology and Oncology, Department of Biochemistry and Molecular Biology, Mayo Clinic Arizona, Scottsdale, Arizona; 3 Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, 4 Mayo Clinic Comprehensive Cancer Center, Genetic Epidemiology and Risk Assessment, and 5 Mayo Clinic Comprehensive Cancer Center, Division of Surgical Oncology, Mayo Clinic Rochester, Rochester, Minnesota; 6 Allergy-Immunology Division, Northwestern University Feinberg School of Medicine, Chicago, Illinois; and 7 National Institute of Environmental Health Sciences, Laboratory of Signal Transduction, Research Triangle Park, North Carolina

Requests for reprints: James J. Lee, Division of Pulmonary Medicine, Department of Biochemistry and Molecular Biology, SCJMRB-Research, Mayo Clinic Arizona, 13400 East Shea Boulevard, Scottsdale, AZ 85259. Phone: 480-301-7183; Fax: 480-301-7017; E-mail: jjlee{at}mayo.edu.

Key Words: Metastasis • Asthma • Endothelial Cell • Diapedesis • Breast Cancer

Allergen-induced respiratory inflammation facilitates and/or elicits the extravasation of proinflammatory leukocytes by well-understood mechanisms that mediate the movement of multiple cell types. The nonspecific character of these pathways led us to hypothesize that circulating cancer cells use similar mechanisms, promoting secondary tumor formation at distal sites. To test this hypothesis, the frequency of metastasis to the lung as a function of allergic pulmonary inflammation was assessed following the i.v. injection of B16-F10 melanoma cells in mice. These studies showed that allergen-induced pulmonary inflammation resulted in a >3-fold increase in lung metastases. This increase was dependent on CD4+ T-cell activities; however, it occurred independent of the induced eosinophilia associated with allergen provocation. Interventional strategies showed that existing therapeutic modalities for asthma, such as inhaled corticosteroids, were sufficient to block the enhanced pulmonary recruitment of cancer cells from circulation. Additional mechanistic studies further suggested that the ability of circulating cancer cells to extravasate to surrounding lung tissues was linked to the activation of the vascular endothelium via one or more G{alpha}i-coupled receptors. Interestingly, a survey of a clinical breast cancer surgical database showed that the incidence of asthma was higher among patients with lung metastases. Thus, our data show that allergic respiratory inflammation may represent a risk factor for the development of lung metastases and suggest that amelioration of the pulmonary inflammation associated with asthma will have a direct and immediate benefit to the 7% to 8% of breast cancer patients with this lung disease. [Cancer Res 2008;68(20):8582–9]




This article has been cited by other articles:


Home page
J. Immunol.Home page
R. Lotfi, G. I. Herzog, R. A. DeMarco, D. Beer-Stolz, J. J. Lee, A. Rubartelli, H. Schrezenmeier, and M. T. Lotze
Eosinophils Oxidize Damage-Associated Molecular Pattern Molecules Derived from Stressed Cells
J. Immunol., October 15, 2009; 183(8): 5023 - 5031.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
A. Varki, N. M. Varki, L. Borsig, J. J. Lee, M. T. Lotze, A. Batistatou, A. Charalabopoulos, K. Charalabopoulos, A. Chiang, and J. Massague
Molecular Basis of Metastasis
N. Engl. J. Med., April 16, 2009; 360(16): 1678 - 1680.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2008 by the American Association for Cancer Research.